Stroke treatment: time is brain.
Hill
M D
MD
Department of Neurology, University of Toronto and St Michael's Hospital, Ontario, Canada.
Hachinski
V
V
D000925:Anticoagulants / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D001921:Brain / Q000503:physiopathology*; D002561:Cerebrovascular Disorders / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005440:Fluid Therapy; D006801:Humans; D010960:Plasminogen Activators / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D000925:Anticoagulants; D001786:Blood Glucose; D005343:Fibrinolytic Agents; D013300:Streptokinase; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator